TherapeuticsMD (TXMD) Misses Q2 EPS by 17c

TherapeuticsMD (NASDAQ: TXMD) reported Q2 EPS of ($0.24), $0.17 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• After-Hours Stock Movers: NKE, BE, STZ, RIG
• Summit Hotel Properties refinances $650M credit facility through 2031